Khandaker Partners & Co. Initiates Research on BioBalance Corp.NEW YORK New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of -- The third sentence of the first graf should read: According to Khandaker Partners Analyst, JianJin (MsFin, CFA (Computer Fraud and Abuse Act of 1986) Signed into law in 1986, the CFA was a significant step forward in criminalizing unauthorized access to computer systems and networks. The Act applies to "federal interest computers" that include any system used by the U.S. Lev -I), "BioBalance Probactrix(R) has great potential in IBS IBS Irritable bowel syndrome, see there market which could prove to be a home run for the company." (sted: According to Khandaker Partners Analyst, Andrew Gaw, CFA, ...) E[acute accent]The corrected release reads as follows: E[acute accent]Khandaker Partners & Co., a Wall Street independent research and advisory firm specializing in small cap and emerging growth companies, announced today that it has initiated research coverage on BioBalance Corporation ("BioBalance"), a wholly-owned subsidiary of New York Health Care, Inc. (the "Company")(OTCBB OTCBB See OTC Bulletin Board (OTCBB). :BBAL). The report indicates that BioBalance received FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approval to begin phase II clinical trials for Probactrix(R), its lead product candidate. According to Khandaker Partners Analyst, JianJin (MsFin, CFA Lev -I), "BioBalance Probactrix(R) has great potential in IBS market which could prove to be a home run for the company." E[acute accent]A copy of the report can be obtained by emailing rripatti@khandaker.com E[acute accent]Probactrix is a patented strain of non-pathogenic E.coli M-17 that was originally isolated from the intestinal microflora microflora /mi·cro·flo·ra/ (-flor´ah) the microscopic vegetable organisms of a special region. Microflora The bacterial population in the intestine. of a healthy volunteer. One mechanism of action is believed to work by selective displacement of pathogenic bacteria Pathogenic bacteria Bacteria that produce illness. Mentioned in: Gastroenteritis in the digestive tract digestive tract n. See alimentary canal. Digestive tract The organs that perform digestion, or changing of food into a form that can be absorbed by the body. and preventing their re-colonization, restoring a healthy balance of intestinal flora without the potential negative consequences of antibiotic use. The active ingredient in Probactrix has a long history of use for a variety of gastrointestinal conditions, which has been well documented in foreign studies. E[acute accent]About Khandaker Partners E[acute accent]Khandaker Partners & Co. (Khandaker) is dedicated exclusively in the emerging growth sectors of healthcare, information technology and energy. Khandaker identifies firms with near term and long term opportunities. The cost of enrollment in our one year micro-cap research portfolio (US$24,000) is paid by the company to support the various research activities. www.khandakerpartners.com E[acute accent]About BioBalance Corporation E[acute accent]BioBalance is a biopharmaceutical company focused on the development of innovative treatments for GI disorders that are poorly addressed by current therapies. These disorders include pouchitis, Irritable Bowel Syndrome irritable bowel syndrome (IBS), condition characterized by frequently alternating constipation and diarrhea in the absence of any disease process. It is usually accompanied by abdominal pain, especially in the lower left quadrant, bloating, and flatulence. (IBS), Crohn's disease, ulcerative colitis, C. difficile infections and antibiotic-associated diarrhea. New York Health Care, Inc. (the "Company") and BioBalance completed a business combination on January 2, 2003, accounted for as a "reverse acquisition," in which BioBalance became a wholly-owned subsidiary of the Company. BioBalance's lead product, Probactrix(R), recently received FDA approval to begin phase II clinical trials for pouchitis. Additional information on BioBalance is located on the BioBalance website at www.biobalance.com. E[acute accent]Forward-Looking Statements: All statements in this press release that are not historical are forward-looking statements. Such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including, but not limited to, uncertainties relating to technologies, product development, manufacturing, market acceptance, cost and pricing of BioBalance products, dependence on collaborations and partners, regulatory approvals, competition, intellectual property of others, and patent protection and litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. . |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion